Daily non-political popular news in brief.
Statin users risk heart attacks by dropping treatment or taking low doses
12-08-2006 · EurekAlert!Thousands of statin users worldwide are suffering preventable heart attacks, simply because they are not complying with their treatment or are taking too low a dose, according to new research published on-line today (Thursday 7 December) in European Heart Journal1.
Read more »
Keywords: statin, users, risk, heart, attacks, dropping, treatment, taking, low, doses, user, attack, dose
« Previous | Next »
Similar news on "Statin users risk heart attacks by dropping treatment or taking low doses":
- Statin users risk heart attacks by dropping treatment or taking low doses
12-06-2006 · EurekAlert!
Thousands of statin users worldwide are suffering preventable heart attacks, simply because they are not complying with their treatment or are taking too low a dose, according to new research published online Thursday, Dec. 7, in European Heart Journal. Doctors must emphasise to patients the importance of complying with treatment, say Dutch researchers.
Similar news · Read more »
- Low-dose aspirin reduces cardiovascular events
11-15-2006 · EurekAlert!
Taking low-dose aspirin daily reduces the risk of heart attack and stroke, as well as the risk of dying, among patients who previously have had a heart attack or stroke but whose cardiovascular disease has stabilized, according to a new analysis by Duke University Medical Center cardiologists.
Similar news · Read more »
- Study analyzes heart attack mortality risk associated with Hodgkin disease treatments
02-06-2007 · EurekAlert!
Doctors have long known that patients treated for Hodgkin disease are at an increased risk for heart attacks. In the February 7 issue of the Journal of the National Cancer Institute, researchers quantify the risk of fatal heart attacks associated with different types of treatment, and they find that the increased risk persists for at least 25 years after Hodgkin disease treatment.
Similar news · Read more »
- New strategy to cut heart attack risk is effective in initial test
12-17-2007 · EurekAlert!
The first clinical trial of a new kind of drug to cut the risk of cardiovascular disease has been found safe and effective at dropping levels of "bad" low density lipoprotein cholesterol by as much as 40 percent. High LDL levels increase the risk for heart attack and stroke.
Similar news · Read more »
- Obese heart attack patients are more likely to survive after treatment than normal weight patients
06-19-2007 · EurekAlert!
Obese and very obese patients have a lower risk of dying after they have been treated for heart attacks than do normal weight patients, according to research published in the European Heart Journal.
Similar news · Read more »
- Obese heart attack patients are more likely to survive after treatment than normal-weight patients
06-19-2007 · EurekAlert!
Obese and very obese patients have a lower risk of dying after they have been treated for heart attacks than do normal weight patients, according to research published in the European Heart Journal.
Similar news · Read more »
- Usefulness of cardiovascular disease test questioned
02-26-2007 · EurekAlert!
Dartmouth/VA researchers show that adding CRP testing to routine assessments would increase the number of Americans eligible for cholesterol-lowering treatment by about two million if used judiciously, and by over 25 million if used broadly -- with most of these people being at low risk for heart attacks or heart disease.
Similar news · Read more »
- Ibuprofen puts high risk cardiac patients at risk
04-05-2007 · EurekAlert!
Doctors who treat the painful condition of osteoarthritis in patients with increased cardiovascular risk need to be cautious. A team lead by researchers at Mount Sinai School of Medicine, are the first to study outcomes in high cardiovascular risk patients with osteoarthritis. They have found that high cardiovascular risk patients taking ibuprofen and aspirin combined are nine times more likely suffer a heart attack.
Similar news · Read more »
- High-dose anticlotting drug cuts heart attack, death risk in half
05-11-2007 · EurekAlert!
Pretreatment with double-dose anticlotting medication just before percutaneous coronary intervention cuts the combined risk of heart attack and cardiac death by half, according to a study reported at the 30th annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions, May 9-12, 2007, in Orlando, Fla.
Similar news · Read more »
- First human trial tests stem-cell-based treatment for heart attacks
03-25-2007 · EurekAlert!
Previous research on the efficacy of stem cell therapy for heart repair has shown possible benefit from mesenchymal stem cells (MSCs) -- cells found in bone marrow that create connective tissue, bone and cartilage. A study presented today at the American College of Cardiology's Innovation in Intervention: i2 Summit reveals the results of the first human trial using MSCs for the treatment of myocardial infarction (MI, or heart attack).
Similar news · Read more »
